ICD-10-CM Billable Code

H04.81

Granuloma of lacrimal passages

Clinical Classification Guidelines

Medical Intelligence & Overview

Granuloma of the lacrimal passages is a rare condition characterized by the formation of granulomas, or small areas of inflammation, within the tear drainage system. This condition can disrupt normal tear flow, leading to discomfort and other eye-related issues. It primarily affects the structures responsible for draining tears from the eyes into the nasal cavity, such as the lacrimal sac and canaliculi. Recognizing this condition early is important for effective management and to prevent complications that could impact vision or eye health.

Causes & Symptoms

Clinical Causes: Chronic infections, such as bacterial or viral infections, that induce inflammation within the lacrimal passages. Trauma or injury to the eye or surrounding tissues, leading to inflammatory responses. Previous surgeries or procedures involving the tear drainage system that may trigger granuloma formation. Foreign bodies or debris lodged in the tear ducts, causing persistent inflammation. Autoimmune conditions that lead to abnormal inflammatory reactions within the lacrimal system.

Key Symptoms: Persistent tearing or watery eyes (epiphora). Swelling or noticeable lump along the tear drainage pathway. Discomfort or tenderness in the affected area. Redness around the eyelids or inner corners of the eyes. Recurrent eye infections, such as conjunctivitis. Irritation or a feeling of fullness in the tear sac. In some cases, blockage may lead to mucus or pus discharge. Reduced tear drainage efficiency, resulting in dryness or irritation.

Diagnostic & Treatment

Diagnosis Path: Diagnosing granuloma of the lacrimal passages typically involves a comprehensive eye examination, including inspection of the eyelids, conjunctiva, and tear drainage pathways. Tests such as dye tests or irrigation of the lacrimal system may be performed to assess blockage or abnormal tissue growth. Imaging studies like dacryocystography or ultrasound may be used to visualize the extent of the granuloma. A thorough medical history, including prior eye conditions or injuries, helps in identifying underlying causes. In some cases, a biopsy of the granuloma tissue may be necessary to confirm the diagnosis and rule out other conditions, including malignancies.

Treatment Protocols: Treatment options aim to alleviate symptoms, remove or reduce the granuloma, and restore normal tear drainage. Approaches may include: - **Medical management:** Use of antibiotics or anti-inflammatory medications to control infection and inflammation. - **Surgical intervention:** Such as excision of the granuloma, dacryocystorhinostomy (creating a new tear drainage pathway), or removal of obstructions. - **Drainage procedures:** To clear blockages and promote proper tear flow. - **Addressing underlying causes:** Managing infections or autoimmune issues contributing to granuloma formation. Follow-up care is essential to monitor healing and prevent recurrence. Treatment plans are tailored to each individual based on the severity and specific characteristics of the granuloma.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H04.81 a billable ICD-10 code?
Yes, H04.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H04.81?
Clinical documentation must specify the nature of Granuloma of lacrimal passages and any associated comorbidities for accurate reporting.

Cite this Clinical Reference